Elevated CRP levels indicate poor progression-free and overall survival on cancer patients treated with PD-1 inhibitors.

Iivanainen, Sanna; Ahvonen, Jarkko; Knuuttila, Aija; Tiainen, Satu; Koivunen, Jussi Pekka

Iivanainen, Sanna; Ahvonen, Jarkko; Knuuttila, Aija; Tiainen, Satu; Koivunen, Jussi Pekka.

Afiliação

Iivanainen S; Department of Oncology and Radiotherapy, MRC Medical Reasearch Center, Oulu University Hospital, Oulu, Finland.
Ahvonen J; Department of Oncology, Tampere University Hospital, Tampere, Finland.
Knuuttila A; Department of Pulmonary Medicine, Heart and Lung Center and Cancer Center, Helsinki University Hospital, Helsinki, Finland.
Tiainen S; Cancer Center, Kuopio University Hospital, Kuopio, Finland.
Koivunen JP; Department of Oncology and Radiotherapy, MRC Medical Reasearch Center, Oulu University Hospital, Oulu, Finland.

ESMO Open ; 4(4): e000531, 2019.

Article em En | MEDLINE | ID: mdl-31555483

Palavras-chave

CRP; PD-1; predictive; prognostic; survival

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: ESMO Open Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Finlândia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google